RET and thyroid tumor: ZD6474 has also demonstrated potent inhibition of ligand-dependent RET receptor tyrosine kinase activity (IC50=100 nM) and selective inhibition of RET-dependent thyroid tumour cell growth in vitro (Carlomagno et al, 2002; Carlomagno et al, 2004).